{"id":11385,"date":"2022-07-01T20:35:02","date_gmt":"2022-07-02T00:35:02","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/antibody-based-therapies-taking-a-bite-out-of-cancer\/"},"modified":"2022-07-14T16:15:18","modified_gmt":"2022-07-14T20:15:18","slug":"targeted-antibody-immunotherapy-webinar-mab-bite","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/targeted-antibody-immunotherapy-webinar-mab-bite","title":{"rendered":"Antibody-Based Therapies: Taking a BiTE Out of Cancer"},"content":{"rendered":"<p style=\"text-align: center;\"><iframe loading=\"lazy\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/Cn2oN5EPQI4\" width=\"560\"><\/iframe><\/p>\n<p>While many know that antibodies attack foreign bacteria and viruses, scientists today are also engineering antibodies to target cancer cells. Just recently, Sir Gregory P. Winter,&nbsp;CBE, FRS, FMedSci, received the&nbsp;2018 Nobel Prize for Chemistry (along with&nbsp;Frances H. Arnold, PhD and George P. Smith, PhD) for the use of phage display to direct the&nbsp;evolution of antibodies&nbsp;in order to create new cancer drugs.<\/p>\n<p>Targeted antibodies are a special type of protein designed to target antigens, or markers, located on the surface of cancer cells. Once the antibodies locate antigens, they can recruit immune cells to attack&nbsp;or interfere with cell signaling, helping to block growth and communication of tumor cells.<\/p>\n<p>In this webinar for patients and caregivers,&nbsp;<a href=\"https:\/\/www.weizmann.ac.il\/immunology\/dahan\/home\" target=\"_blank\" rel=\"noopener\"><strong>Rony Dahan, PhD<\/strong><\/a>, of&nbsp;Weizmann Institute of Science (Israel)&nbsp;discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.&nbsp;<\/p>\n<p><img decoding=\"async\" alt=\"Rony Dahan Weizman Institute\" src=\"\/CRI\/media\/Events\/Rony-Dahan.jpg\" style=\"float: left; margin: 10px;\" \/>Dr. Dahan completed his PhD in Molecular Immunology at the Technion in 2010. He served as a postdoctoral fellow in Cancer Immunology at the Laboratory of Jeffrey Ravetch, MD, PhD,&nbsp;at Rockefeller University in New York from 2013 until joining the faculty of the Weizmann Institute of Science in August 2017.&nbsp;Rony Dahan&rsquo;s Lab in the Department of Immunology at Weizmann Institute of Science studies antibody effector functions in cancer immunology and immunotherapy.<\/p>\n<p>The &quot;Cancer Immunotherapy and You&quot; webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune.<\/p>\n<p>Browse our <a href=\"https:\/\/www.youtube.com\/playlist?list=PLiGDIj2dVt-iOiV34MnZIkTiVF3iFgF_o\" target=\"_blank\" rel=\"noopener\">Cancer Immunotherapy and You Webinar Series playlist<\/a> on YouTube or visit the <a href=\"\/events\/webinars\">Webinars page<\/a> on our website to see other webinars in this series.<\/p>\n<p style=\"text-align: center;\"><img decoding=\"async\" alt=\"2018 Cancer Immunotherapy and You Webinar Series Sponsors Bristol-Myers Squibb, Sanofi Genzyme, Regeneron, Adaptimmune\" src=\"\/CRI\/media\/Events\/Webinar_Sponsors_website_2018-calendar-year.png\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.&nbsp;<\/p>\n","protected":false},"featured_media":2248,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11385","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Webinar: Antibody-Based Therapies<\/title>\n<meta name=\"description\" content=\"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinar: Antibody-Based Therapies\" \/>\n<meta property=\"og:description\" content=\"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:15:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7a4ed60b-013a-41ff-b59c-55c416e34ecf.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Webinar: Antibody-Based Therapies\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7a4ed60b-013a-41ff-b59c-55c416e34ecf.png\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite\",\"name\":\"Webinar: Antibody-Based Therapies\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/41e6e878-bd77-42f9-922b-a4249b29d860.png\",\"datePublished\":\"2022-07-02T00:35:02+00:00\",\"dateModified\":\"2022-07-14T20:15:18+00:00\",\"description\":\"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/41e6e878-bd77-42f9-922b-a4249b29d860.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/41e6e878-bd77-42f9-922b-a4249b29d860.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Antibody-Based Therapies: Taking a BiTE Out of Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webinar: Antibody-Based Therapies","description":"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite","og_locale":"es_ES","og_type":"article","og_title":"Webinar: Antibody-Based Therapies","og_description":"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.","og_url":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:15:18+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7a4ed60b-013a-41ff-b59c-55c416e34ecf.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Webinar: Antibody-Based Therapies","twitter_description":"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7a4ed60b-013a-41ff-b59c-55c416e34ecf.png","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite","url":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite","name":"Webinar: Antibody-Based Therapies","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/41e6e878-bd77-42f9-922b-a4249b29d860.png","datePublished":"2022-07-02T00:35:02+00:00","dateModified":"2022-07-14T20:15:18+00:00","description":"Dr. Rony Dahan of Weizmann Institute of Science (Israel) discusses the latest advances in targeted antibodies for the effective treatment of many forms of cancer.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/41e6e878-bd77-42f9-922b-a4249b29d860.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/41e6e878-bd77-42f9-922b-a4249b29d860.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/targeted-antibody-immunotherapy-webinar-mab-bite#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Antibody-Based Therapies: Taking a BiTE Out of Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/2248"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11385"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11385"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11385"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11385"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11385"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11385"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}